Authors:
BREISTOL K
HENDRIKS HR
BERGER DP
LANGDON SP
FIEBIG HH
FODSTAD O
Citation: K. Breistol et al., THE ANTITUMOR-ACTIVITY OF THE PRODRUG N-L-LEUCYL-DOXORUBICIN AND ITS PARENT COMPOUND DOXORUBICIN IN HUMAN TUMOR XENOGRAFTS, European journal of cancer, 34(10), 1998, pp. 1602-1606
Authors:
HOMANN D
TISHON A
BERGER DP
WEIGLE WO
VONHERRATH MG
OLDSTONE MBA
Citation: D. Homann et al., EVIDENCE FOR AN UNDERLYING CD4 HELPER AND CD8 T-CELL DEFECT IN B-CELL-DEFICIENT MICE - FAILURE TO CLEAR PERSISTENT VIRUS-INFECTION AFTER ADOPTIVE IMMUNOTHERAPY WITH VIRUS-SPECIFIC MEMORY CELLS FROM MU-MT MU-MTMICE/, Journal of virology (Print), 72(11), 1998, pp. 9208-9216
Authors:
NEUMANN HPH
BENDER BU
BERGER DP
LAUBENBERGER J
SCHULTZESEEMANN W
WETTERAUER U
FERSTL FJ
HERBST EW
SCHWARZKOPF G
HES FJ
LIPS CJM
LAMIELL JM
MASEK O
RIEGLER P
MUELLER B
GLAVAC D
BRAUCH H
Citation: Hph. Neumann et al., PREVALENCE, MORPHOLOGY AND BIOLOGY OF RENAL-CELL CARCINOMA IN VON-HIPPEL-LINDAU-DISEASE COMPARED TO SPORADIC RENAL-CELL CARCINOMA, The Journal of urology, 160(4), 1998, pp. 1248-1254
Authors:
BURGER JA
OCHS A
WIRTH K
BERGER DP
MERTELSMANN R
ENGELHARDT R
ROESSLE M
HAAG K
Citation: Ja. Burger et al., THE TRANSJUGULAR STENT IMPLANTATION FOR THE TREATMENT OF MALIGNANT PORTAL AND HEPATIC VEIN OBSTRUCTION IN CANCER-PATIENTS, Annals of oncology, 8(2), 1997, pp. 200-202
Authors:
WEISSENBERGER C
HECK S
BERGER DP
HERBSTRITT L
SCHULZKE S
DENGLER WA
MERTELSMANN R
FIEBIG HH
Citation: C. Weissenberger et al., CORRELATION BETWEEN EXPRESSION OF MDR1, GST-PI, K-RAS, MDR3, CEA IN HUMAN TUMOR XENOGRAFTS, European journal of cancer, 31A, 1995, pp. 105-105
Authors:
BERGER DP
HERBSTRITT L
HELLERICH U
SCHULZKE S
DENGLER WA
GALLO M
PASTAN I
MERTELSMANN R
FIEBIG HH
Citation: Dp. Berger et al., CYTOTOXICITY OF TGF-ALPHA-PE40 AND CORRELATION TO EXPRESSION OF EPIDERMAL GROWTH-FACTOR RECEPTOR, European journal of cancer, 31A(12), 1995, pp. 2067-2072
Authors:
DENGLER WA
SCHULTE J
BERGER DP
MERTELSMANN R
FIEBIG HH
Citation: Wa. Dengler et al., DEVELOPMENT OF A PROPIDIUM IODIDE FLUORESCENCE ASSAY FOR PROLIFERATION AND CYTOTOXICITY ASSAYS, Anti-cancer drugs, 6(4), 1995, pp. 522-532
Authors:
BERGER DP
HERBSTRITT L
DENGLER WA
MARME D
MERTELSMANN R
FIEBIG HH
Citation: Dp. Berger et al., VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) MESSENGER-RNA EXPRESSION INHUMAN TUMOR-MODELS OF DIFFERENT HISTOLOGIES, Annals of oncology, 6(8), 1995, pp. 817-825
Authors:
LANGDON SP
HENDRIKS HR
BRAAKHUIS BJM
PRATESI G
BERGER DP
FODSTAD O
FIEBIG HH
BOVEN E
Citation: Sp. Langdon et al., PRECLINICAL PHASE-II STUDIES IN HUMAN TUMOR XENOGRAFTS - A EUROPEAN MULTICENTER FOLLOW-UP-STUDY, Annals of oncology, 5(5), 1994, pp. 415-422
Authors:
NEUMANN HPH
BERGER DP
SIGMUND G
BLUM U
SCHMIDT D
PARMER RJ
VOLK B
KIRSTE G
Citation: Hph. Neumann et al., PHEOCHROMOCYTOMAS, MULTIPLE ENDOCRINE NEOPLASIA TYPE-2, AND VONHIPPEL-LINDAU DISEASE, The New England journal of medicine, 329(21), 1993, pp. 1531-1538